Report an error

Spotted something inaccurate in “ELIOS Trial Maps Resistance Pathways in EGFR-Mutant Lung Cancer After Osimertinib”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.